---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-008280"
form_type: "8-K"
ticker: "PRLD"
cik: "0001678660"
company_name: "Prelude Therapeutics Inc"
filed_at: "2026-01-09T23:59:59+00:00"
generated_at: "2026-05-16T11:04:28.420693+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Prelude Therapeutics furnishes investor presentation; no material new information disclosed

## Summary
- Filed an investor presentation dated January 2026 for use in investor meetings starting Jan 9.
- The presentation includes forward-looking statements and general corporate overview.
- No specific new clinical data, financial results, or corporate milestones were released.
- The filing is a routine Regulation FD disclosure; presentation content not provided in full detail.

## SEC filing metadata
- accession: 0001193125-26-008280
- form_type: 8-K
- ticker: PRLD
- cik: 0001678660
- company_name: Prelude Therapeutics Inc
- filed_at: 2026-01-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1678660/000119312526008280/0001193125-26-008280-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1678660/000119312526008280/prld-20260109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-008280
- JSON: https://secwatch.observer/filing/0001193125-26-008280.json
- Plain text: https://secwatch.observer/filing/0001193125-26-008280.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.